Author

Daniel J. Lindner

Cleveland ClinicORCID 0000-0002-8296-7703Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Anand BhushaniD· 1 shared Anchal AgarwaliD· 1 shared Anton A. KomariD· 1 shared Arda DurmaziD· 1 shared Babal Kant JhaiD· 1 shared Caroline SchuergeriD· 1 shared Elise G. Holvey-Bates· 1 shared George Robert StarkiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anand BhushanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Urothelial-lineage master transcription factor hub proteomics shows mechanisms impeding urothelial cancer cell differentiation

Caroline Schuerger, Sudipta Biswas, Kwok Peng Ng, Lisa Cardone, Xiaorong Gu, Shinjini Ganguly, Rita Tohmé, Arda Durmaz, Maximilian Stich, Daniel J. Lindner, Babal Kant Jha, Omar Y. Mian, Yogen Saunthararajah

The paper identifies CoA and CoR dysregulation in urothelial cancer cells and shows that CoR inhibition can restore differentiation.

bioRxiv · Aug 17, 2026 · PreprintCancer Biology

METTL16 promotes taxane resistance in Triple-Negative Breast Cancer through m6A-dependent translational upregulation of ABCB1

Elise G. Holvey-Bates, Jesse A. Coker, Daniel J. Lindner, Anchal Agarwal, Anand Bhushan, Yvonne Parker, Hannah L. Gilmore, Anton A. Komar, George Robert Stark, Sarmishtha De

This study identifies METTL16 as a driver of taxane resistance in TNBC by enhancing ABCB1 translation via m6A modification, showing its therapeutic potential.

bioRxiv · Mar 13, 2026 · PreprintCancer Biology